Over the last 10 years, insiders at Mylan NV have traded over 1,861,785,794$ worth of Mylan NV stock and bought 202,008 units worth 5,767,632$ . The most active insiders traders include Laboratories Abbott Product...、Daniel Martin Jr Gallagher、Robert J Coury. On average, Mylan NV executives and independent directors trade stock every 15 days with the average trade being worth of 5,605,891$. The most recent stock trade was executed by Robert J Cindrich on 16 November 2020, trading 9,440 units of MYL stock currently worth 149,624$.
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Mylan NV executives and other stock owners filed with the SEC include: